Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep. 40 Midurethral Slings vs. Bulkamid: What Clinicians Need to Know! with Dr Tamsin Greenwell

Ep. 40 Midurethral Slings vs. Bulkamid: What Clinicians Need to Know! with Dr Tamsin Greenwell

FromBackTable OBGYN


Ep. 40 Midurethral Slings vs. Bulkamid: What Clinicians Need to Know! with Dr Tamsin Greenwell

FromBackTable OBGYN

ratings:
Length:
45 minutes
Released:
Dec 6, 2023
Format:
Podcast episode

Description

In this episode of the Backtable OBGYN Podcast, host Dr. Suzette Sutherland (University of Washington) and Dr. Tamsin Greenwell (University College London Hospitals) discuss surgical treatments for incontinence and their comparative efficacies.

They focus mainly on midurethral slings and a new urethral bulking agent called Bulkamid. They further analyze how conditions like product expectations, surgeon expertise, data availability, patient preferences, and financial costs influence the choice of procedure. Additionally, they discuss the impact of mesh-related complications and how they affected the usage of synthetic slings in the UK. Finally, they touch on the role of shared decision making in choosing treatment strategies.

---

EARN CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/p4RNfi

---

SHOW NOTES

00:00 - Introduction
03:48 - Discussion on Midurethral Slings
11:05 - The Mesh Controversy and Its Impact
22:21 - Shared Decision Making in Treatment Options
26:47 - The Role of Urethral Bulking Agents
32:51 - Comparative Trial and EAU Guidelines
42:12 - Conclusion and Closing Remarks

---

RESOURCES

Bulkamid Injections
https://bulkamid.com/en-US
Released:
Dec 6, 2023
Format:
Podcast episode

Titles in the series (60)

The BackTable OBGYN Podcast is a resource for practicing OBGYN's to learn tips, techniques, and practical advice from their peers in the field. Listen here or on the streaming platform of your choice.